New Zealand markets closed

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.54-0.83 (-1.25%)
At close: 04:00PM EDT
65.55 +0.01 (+0.02%)
After hours: 04:09PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
512,287
462,175
249,132
81,708
22,531
-
Cost of revenue
36,894
33,745
20,443
8,035
1,895
-
Gross profit
475,393
428,430
228,689
73,673
20,636
-
Operating expenses
Research development
184,951
180,142
134,715
88,845
65,782
-
Selling general and administrative
424,026
409,864
358,782
272,611
186,364
-
Total operating expenses
607,334
587,811
492,315
359,361
251,864
-
Operating income or loss
-131,941
-159,381
-263,626
-285,688
-231,228
-
Income before tax
-109,883
-139,038
-256,250
-284,120
-226,992
-
Income tax expense
985
636
6
6
14
-
Income from continuing operations
-110,868
-139,674
-256,256
-284,126
-227,006
-
Net income
-110,868
-139,674
-256,256
-284,126
-227,006
-
Net income available to common shareholders
-110,868
-139,674
-256,256
-284,126
-227,006
-
Basic EPS
-1.62
-
-2.72
-3.50
-3.23
-2.68
Diluted EPS
-1.62
-
-2.72
-3.50
-3.23
-2.68
Basic average shares
95,499
-
94,047
81,253
70,365
55,186
Diluted average shares
95,499
-
94,047
81,253
70,365
55,186